Cancer Therapy

Company reports advancements in several pipeline programs at AACR meeting

Published in Vaccine Weekly, May 5th, 2004

ImClone Systems Inc. (IMCL) presented preclinical data highlighting progress made in the development of several pipeline programs at the 95th annual meeting of the American Association for Cancer Research (AACR).

"This year's pipeline presentations at the AACR annual meeting are especially exciting for us because many of the research programs being discussed are nearing the clinical phase of development," said Daniel S. Lynch, CEO of ImClone Systems. "Utilizing these data and other preclinical research, ImClone Systems is working toward the filing of investigational new drug applications over the next 18 months to advance several programs into clinical trials, including...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2004-05-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry